Leonardo Drs, Inc. (DRS)

$21.67

+0.28

(+1.31%)▲

Market is closed - opens 7 PM, 29 Apr 2024

Insights on Leonardo Drs, Inc.

  • Increasing Revenue

    Revenue is up for the last 4 quarters, 569.0M → 926.0M (in $), with an average increase of 14.7% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 4 quarters, 12.0M → 74.0M (in $), with an average increase of 42.6% per quarter

  • Vs GE

    In the last 1 year, General Electric Company has given 67.6% return, outperforming this stock by 22.8%

Performance

  • $21.48
    $21.79
    $21.67
    downward going graph

    0.88%

    Downside

    Day's Volatility :1.4%

    Upside

    0.53%

    downward going graph
  • $14.12
    $24.00
    $21.67
    downward going graph

    34.84%

    Downside

    52 Weeks Volatility :41.17%

    Upside

    9.71%

    downward going graph

Returns

PeriodLeonardo Drs, Inc.Index (Russel 2000)
3 Months
9.24%
0.0%
6 Months
12.52%
0.0%
1 Year
44.82%
2.2%
3 Years
94.63%
-23.0%

Highlights

Market Capitalization
5.7B
Book Value
$8.86
Earnings Per Share (EPS)
0.64
PE Ratio
33.61
Wall Street Target Price
25.2
Profit Margin
5.95%
Operating Margin TTM
12.53%
Return On Assets TTM
3.98%
Return On Equity TTM
7.55%
Revenue TTM
2.8B
Revenue Per Share TTM
10.81
Quarterly Revenue Growth YOY
12.9%
Gross Profit TTM
575.0M
EBITDA
327.0M
Diluted Eps TTM
0.64
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.8
EPS Estimate Next Year
0.96
EPS Estimate Current Quarter
0.3
EPS Estimate Next Quarter
0.12

Analyst Recommendation

Buy
    88%Buy
    11%Hold
    0
    0%Sell
Based on 9 Wall street analysts offering stock ratings for Leonardo Drs, Inc.(by analysts ranked 0 to 5 stars)
Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
7
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 16.29%

Current $21.67
Target $25.20

Company Financials

FY18Y/Y Change
Revenue
2.3B
↑ 8810.7%
Net Income
-10.0M
↓ 546.63%
Net Profit Margin
-0.43%
↓ 8.98%
FY19Y/Y Change
Revenue
2.7B
↑ 16.33%
Net Income
75.0M
↓ 850.0%
Net Profit Margin
2.76%
↑ 3.19%
FY20Y/Y Change
Revenue
2.8B
↑ 2.36%
Net Income
85.0M
↑ 13.33%
Net Profit Margin
3.06%
↑ 0.3%
FY21Y/Y Change
Revenue
2.9B
↑ 3.64%
Net Income
154.0M
↑ 81.18%
Net Profit Margin
5.35%
↑ 2.29%
FY22Y/Y Change
Revenue
2.7B
↓ 6.46%
Net Income
405.0M
↑ 162.99%
Net Profit Margin
15.04%
↑ 9.69%
FY23Y/Y Change
Revenue
2.8B
↑ 4.94%
Net Income
168.0M
↓ 58.52%
Net Profit Margin
5.94%
↓ 9.1%
Q3 FY22Q/Q Change
Revenue
634.0M
↑ 1.12%
Net Income
279.0M
↑ 1016.0%
Net Profit Margin
44.01%
↑ 40.02%
Q4 FY22Q/Q Change
Revenue
820.0M
↑ 29.34%
Net Income
65.0M
↓ 76.7%
Net Profit Margin
7.93%
↓ 36.08%
Q1 FY23Q/Q Change
Revenue
569.0M
↓ 30.61%
Net Income
12.0M
↓ 81.54%
Net Profit Margin
2.11%
↓ 5.82%
Q2 FY23Q/Q Change
Revenue
628.0M
↑ 10.37%
Net Income
35.0M
↑ 191.67%
Net Profit Margin
5.57%
↑ 3.46%
Q3 FY23Q/Q Change
Revenue
703.0M
↑ 11.94%
Net Income
47.0M
↑ 34.29%
Net Profit Margin
6.69%
↑ 1.12%
Q4 FY23Q/Q Change
Revenue
926.0M
↑ 31.72%
Net Income
74.0M
↑ 57.45%
Net Profit Margin
7.99%
↑ 1.3%
FY18Y/Y Change
Total Assets
53.5M
↑ 48.49%
Total Liabilities
11.3M
↑ 50.44%
FY19Y/Y Change
Total Assets
2.9B
↑ 5297.93%
Total Liabilities
1.9B
↑ 16455.94%
FY20Y/Y Change
Total Assets
3.0B
↑ 2.35%
Total Liabilities
1.5B
↓ 18.19%
FY21Y/Y Change
Total Assets
3.1B
↑ 3.82%
Total Liabilities
1.5B
↓ 3.47%
FY22Y/Y Change
Total Assets
3.7B
↑ 19.81%
Total Liabilities
1.6B
↑ 5.01%
FY23Y/Y Change
Total Assets
4.0B
↑ 9.84%
Total Liabilities
1.7B
↑ 10.58%
Q3 FY22Q/Q Change
Total Assets
2.9B
↓ 3.68%
Total Liabilities
1.4B
↑ 0.58%
Q4 FY22Q/Q Change
Total Assets
3.7B
↑ 25.45%
Total Liabilities
1.6B
↑ 11.27%
Q1 FY23Q/Q Change
Total Assets
3.7B
↑ 0.11%
Total Liabilities
1.5B
↓ 0.77%
Q2 FY23Q/Q Change
Total Assets
3.7B
↓ 0.52%
Total Liabilities
1.5B
↓ 4.23%
Q3 FY23Q/Q Change
Total Assets
3.7B
↑ 1.39%
Total Liabilities
1.5B
↓ 0.14%
Q4 FY23Q/Q Change
Total Assets
4.0B
↑ 8.78%
Total Liabilities
1.7B
↑ 16.52%
FY18Y/Y Change
Operating Cash Flow
105.0M
↑ 9640.26%
Investing Cash Flow
-46.0M
↑ 2312.17%
Financing Cash Flow
-30.0M
↓ 365.67%
FY19Y/Y Change
Operating Cash Flow
157.0M
↑ 49.52%
Investing Cash Flow
-151.0M
↑ 228.26%
Financing Cash Flow
-1000.0K
↓ 96.67%
FY20Y/Y Change
Operating Cash Flow
125.0M
↓ 20.38%
Investing Cash Flow
-70.0M
↓ 53.64%
Financing Cash Flow
-80.0M
↑ 7900.0%
FY21Y/Y Change
Operating Cash Flow
178.0M
↑ 42.4%
Investing Cash Flow
39.0M
↓ 155.71%
Financing Cash Flow
-38.0M
↓ 52.5%
FY22Y/Y Change
Operating Cash Flow
33.0M
↓ 81.46%
Investing Cash Flow
436.0M
↑ 1017.95%
Financing Cash Flow
-403.0M
↑ 960.53%
Q3 FY22Q/Q Change
Operating Cash Flow
-4.0M
↓ 130.77%
Investing Cash Flow
470.0M
↓ 5322.22%
Financing Cash Flow
-472.0M
↑ 883.33%
Q4 FY22Q/Q Change
Operating Cash Flow
279.0M
↓ 7075.0%
Investing Cash Flow
436.0M
↓ 7.23%
Financing Cash Flow
-24.0M
↓ 94.92%
Q1 FY23Q/Q Change
Operating Cash Flow
-334.0M
↓ 219.71%
Investing Cash Flow
-14.0M
↓ 103.21%
Financing Cash Flow
216.0M
↓ 1000.0%
Q2 FY23Q/Q Change
Operating Cash Flow
-12.0M
↓ 96.41%
Investing Cash Flow
-12.0M
↓ 14.29%
Financing Cash Flow
-115.0M
↓ 153.24%
Q3 FY23Q/Q Change
Operating Cash Flow
36.0M
↓ 400.0%
Investing Cash Flow
-42.0M
↑ 250.0%
Financing Cash Flow
-8.0M
↓ 93.04%

Technicals Summary

Sell

Neutral

Buy

Leonardo Drs, Inc. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Leonardo Drs, Inc.
Leonardo Drs, Inc.
-2.11%
12.52%
44.82%
94.63%
94.63%
Rtx Corp
Rtx Corp
5.88%
28.5%
4.13%
25.57%
-27.75%
Boeing Company, The
Boeing Company, The
-11.03%
-6.86%
-17.84%
-30.91%
-56.19%
Lockheed Martin Corporation
Lockheed Martin Corporation
4.21%
4.22%
0.68%
24.95%
41.56%
General Dynamics Corporation
General Dynamics Corporation
2.35%
18.44%
32.62%
53.84%
59.99%
General Electric Company
General Electric Company
-7.08%
48.22%
67.61%
48.54%
110.63%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Leonardo Drs, Inc.
Leonardo Drs, Inc.
33.61
33.61
NA
0.8
0.08
0.04
NA
8.86
Rtx Corp
Rtx Corp
39.77
39.77
0.86
5.39
0.05
0.02
0.02
45.5
Boeing Company, The
Boeing Company, The
58.37
NA
6.53
-0.51
0.0
0.01
NA
-28.27
Lockheed Martin Corporation
Lockheed Martin Corporation
16.81
16.81
4.44
26.03
0.83
0.1
0.03
27.82
General Dynamics Corporation
General Dynamics Corporation
23.37
23.37
1.75
14.61
0.17
0.04
0.02
77.97
General Electric Company
General Electric Company
41.89
41.89
2.03
3.9
0.14
0.02
0.01
27.28
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Leonardo Drs, Inc.
Leonardo Drs, Inc.
Buy
$5.7B
94.63%
33.61
5.95%
Rtx Corp
Rtx Corp
Hold
$134.3B
-27.75%
39.77
4.9%
Boeing Company, The
Boeing Company, The
Buy
$100.9B
-56.19%
58.37
-2.86%
Lockheed Martin Corporation
Lockheed Martin Corporation
Hold
$110.4B
41.56%
16.81
9.73%
General Dynamics Corporation
General Dynamics Corporation
Buy
$80.3B
59.99%
23.37
7.84%
General Electric Company
General Electric Company
Buy
$174.3B
110.63%
41.89
5.05%

Company Information

leonardo drs is a prime contractor, leading technology innovator and supplier of integrated products, services and support to military forces, intelligence agencies and defense contractors worldwide. the company specializes in naval and maritime systems, ground combat mission command and network computing, global satellite communications and network infrastructure, avionics systems, and intelligence and security solutions. additionally, the company builds power systems and electro-optical/infrared systems for a wide range of commercial customers. headquartered in arlington, virginia, leonardo drs is a wholly owned subsidiary of leonardo s.p.a., which employs more than 47,000 people worldwide. see the full range of capabilities at www.leonardodrs.com and on twitter @drstechnologies.

Organization
Leonardo Drs, Inc.
Employees
6600
CEO
Mr. William J. Lynn III
Industry
Industrials

Discover More

FAQs